Interaction of ebeinone, an alkaloid from Fritellaria imperialis, at two muscarinic acetylcholine receptor subtypes

Life Sciences

Volumn 60, Issue 8, 1997, Pages 535-544

  Gilani, A H ^a   Shaheen, F ^a   Christopoulos, A ^b   Mitchelson, F ^b  

^a AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

^b MONASH UNIVERSITY   (Australia)

Author keywords

allosteric interaction; ebeinone; muscarinic acetylcholine receptors; pancuronium

Indexed keywords

ALKALOID; ATROPINE; CARBACHOL; EBEINONE; FRITILLARIA IMPERIALIS EXTRACT; METHYLSCOPOLAMINE; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; PANCURONIUM; PLANT EXTRACT; RADIOLIGAND; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ALLOSTERISM; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG ANTAGONISM; DRUG ISOLATION; DRUG RECEPTOR BINDING; FEMALE; GUINEA PIG; HEART ATRIUM CONTRACTILITY; HEART LEFT ATRIUM; ILEUM; MALE; NONHUMAN; RAT; RECEPTOR AFFINITY; SMOOTH MUSCLE CONTRACTILITY; TRACHEA;

ALKALOIDS; ALLOSTERIC SITE; ANIMALS; GUINEA PIGS; HEART ATRIA; ILEUM; PLANTS; RADIOLIGAND ASSAY; RATS; RECEPTORS, MUSCARINIC; TRACHEA;

ANIMALIA; CAVIA PORCELLUS; FRITILLARIA IMPERIALIS; SUS SCROFA;

EID: 0031575396     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(96)00691-1     Document Type: Article

References (19)

1. 1. A. H. GILANI., N. MOLTA, ATTA-UR-RAHMAN and B. H. SHAH, J. Pharm, Med. 2 111-118 (1992).
2. 2. A. H. GILANI and L.B. COBBIN, Naunyn-Schmied. Arch. Pharmacol. 332 16-20 (1986).
3. 3. A. H. GILANI and L. B. COBBIN, Arch. Int. Pharmacodyn. Ther. 290 46-53 (1987).
4. 4. M. P. CAULFIELD, Pharmac. Ther. 58 319-379 (1993).
5. 5. ATTA-UR-RAHMAN, A. FAROOQ, M. I. CHOUDHARY, A. H. GILANI, F. SHAHEEN, R. A. ALI, F. NOOR-E-AIN and B. SENER, Planta Med. 60 377-379 (1994).
6. 6. P. R. SAXENA and I. L. BONTA, Eur. J. Pharmacol. 11 332-341 (1970).
7. 7. O. ARUNLAKSHANA and H. O. SCHILD, Brit. J. Pharmacol. 14 48-58 (1959).
8. 8. Y.-C. CHENG and W. H. PRUSOFF, Biochem. Pharmacol. 22 3099-3108 (1973)
9. 9. A. CHRISTOPOULOS and F. MITCHELSON, Mol. Pharmacol. 46 105-114 (1994).
10. 10. R. J. MARSHALL, J. C. McGRATH, R. D. MILLER, J. R. DOCHERTY and J. -C. LAMAR, Brit. J. Anaesth. 52 21S-32S (1980).
11. 11. J. NEDOMA, N. A. DOROFEEVA, S. TUCEK, A. SHELKOVNIKOV and A. F. DANILOV, Naunyn-Schmied. Arch. Pharmacol. 329 176-181 (1985).
12. 12. E. LEUNG and F. MITCHELSON, Eur. J. Pharmacol. 80 1-9 (1982).
13. 13. J. DUNLAP and J. H. BROWN, Mol. Pharmacol. 24 15-22 (1983).
14. 14. N. H. LEE and E. E. EL-FAKAHANY, Biochem. Pharmacol. 42 199-205 (1991).
15. 15. J. NEDOMA, S. TUCEK, A. F. DANILOV and A. SHELKOVNIKOV, J. Pharmacol. Exp. Therap. 236 219-223 (1986).
16. 16. J. M. STOCKTON, N. J. M. BIRDSALL, A. S. V. BURGEN and E. C. HULME, Mol. Pharmacol. 23 551-557 (1983).
17. 17. S. TUCEK, J. MUSILKOVA, J. NEDOMA, J. PROŠKA, S. W. SHELKOVNIKOV and J. VORLICEK, Mol. Pharmacol. 38 674-680 (1990).
18. 18. N. H. LEE and E. E. EL-FAKAHANY, J. Pharmacol. Exp. Ther. 246 829-838 (1988).
19. 19. A. CHRISTOPOULOS and F. MITCHELSON, Eur. J. Pharmacol. (Molec. Pharmacol. Sect.) 290 259-262 (1995).